Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$122.71 - $146.91 $1.62 Million - $1.93 Million
13,170 New
13,170 $1.88 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $438,900 - $527,250
5,000 New
5,000 $517,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track United American Securities Inc. (D Portfolio

Follow United American Securities Inc. (D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United American Securities Inc. (D, based on Form 13F filings with the SEC.

News

Stay updated on United American Securities Inc. (D with notifications on news.